Literature DB >> 9849337

Use of a thromboembolic risk score to improve thromboprophylaxis in surgical patients.

G Harinath1, P H St John.   

Abstract

Two hundred admissions to a general surgical ward were audited prospectively before and after the introduction of a thromboembolic risk score. This was based on the Thromboembolic Risk Factors (THRIFT) Consensus Group guidelines for thrombo-prophylaxis. The results showed an overall improvement in compliance from 65% to 79%. High risk patients formed 24% of the patients studied. In this group, compliance improved significantly from 14% to 58%. The overall prevalence of important thromboembolic risk factors was calculated. Of the patients, 26.5% had a Body Mass Index (BMI) of > 25, and 10% gave a past or family history of thromboembolism. Of female patients, 24% were taking oestrogens. We conclude that quantitative assessment of all patients for thromboembolic risk can improve the implementation of thromboprophylaxis, particularly in high risk patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9849337      PMCID: PMC2503127     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  7 in total

1.  Activated protein C resistance: the commonest hereditary hypercoagulation disorder.

Authors:  K L Schuster; D Jentschura
Journal:  Br J Surg       Date:  1997-12       Impact factor: 6.939

2.  Protocol violation in deep vein thrombosis prophylaxis.

Authors:  B D George; T A Cook; I J Franklin; J Nethercliff; R B Galland
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

3.  Audit of thromboembolic prophylaxis in hip and knee surgery.

Authors:  H R Williams; D A Macdonald
Journal:  Ann R Coll Surg Engl       Date:  1997-01       Impact factor: 1.891

4.  Oral contraceptives and venous thromboembolism: findings in a large prospective study.

Authors:  M Vessey; D Mant; A Smith; D Yeates
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

Review 5.  Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.

Authors:  R Collins; A Scrimgeour; S Yusuf; R Peto
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

6.  World distribution of factor V Leiden.

Authors:  D C Rees; M Cox; J B Clegg
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

7.  Risk of venous thromboembolism in users of hormone replacement therapy.

Authors:  E Daly; M P Vessey; M M Hawkins; J L Carson; P Gough; S Marsh
Journal:  Lancet       Date:  1996-10-12       Impact factor: 79.321

  7 in total
  2 in total

Review 1.  A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals.

Authors:  Rebecca Tooher; Philippa Middleton; Clarabelle Pham; Robert Fitridge; Siohban Rowe; Wendy Babidge; Guy Maddern
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

2.  Venous thromboprophylaxis in UK medical inpatients.

Authors:  S T Rashid; M R Thursz; N A Razvi; R Voller; T Orchard; S T Rashid; A A Shlebak
Journal:  J R Soc Med       Date:  2005-11       Impact factor: 18.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.